Cervical artery dissection (CAD) is one of the most frequent causes (14.5%) of stroke in young adults. Cases with involvement of more than two arteries are rare. Arnold et al described 11 cases (1.5%) with triple CAD of a reported 740 patients and just a single (0.1%) quadruple case in the same population. Simultaneous dissection of the four principal vessels is extremely rare. According to Papagiannaki et al, the incidence of simultaneous three or four CADs is 1-3/million in the general population. To the best of our knowledge, there are only three published cases of spontaneous quadruple CAD.
Objective: to report a case of recurrent chronic subdural hematoma treated using endovascular superselective embolization of the middle meningeal artery with the SQUID-18 non-adhesive embolic agent.Materials and methods. A 73-year-old male patient had an open head injury after own height falling. Multislice computed tomography demonstrated chronic subdural hematoma in the left parietooccipital region. The patient had surgery with a positive effect; however, 1 month postoperatively he developed recurrent hematoma. He was diagnosed with recurrent chronic subdural hematoma and underwent endovascular embolization of the distal branches of the middle meningeal artery with a non-adhesive embolic agent; repeated hematoma drainage was not required.Results. Follow-up multislice computed tomography performed 7 months postoperatively demonstrated total resorption of chronic subdural hematoma.Conclusion. This case illustrates the variety of methods that can be used for the treatment of chronic subdural hematoma and shows that endovascular embolization of the middle meningeal artery is a minimally invasive and effective procedure for such a disorder.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.